First Time Loading...

Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 150.1 USD 0.58%
Updated: Jul 16, 2024
Have any thoughts about
Johnson & Johnson?
Write Note

Relative Value

The Relative Value of one JNJ stock under the Base Case scenario is 181.45 USD. Compared to the current market price of 150.1 USD, Johnson & Johnson is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

JNJ Relative Value
Base Case
181.45 USD
Undervaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
79
vs Industry
30
Median 3Y
5
Median 5Y
4.6
Industry
2.3
Forward
4.1
vs History
95
vs Industry
37
Median 3Y
22.9
Median 5Y
22.7
Industry
21.8
Forward
14
vs History
71
vs Industry
26
Median 3Y
18.1
Median 5Y
16.8
Industry
16.2
vs History
3
vs Industry
11
Median 3Y
21.4
Median 5Y
19.5
Industry
22.8
vs History
88
vs Industry
14
Median 3Y
5.7
Median 5Y
5.7
Industry
2
vs History
79
vs Industry
27
Median 3Y
5.1
Median 5Y
4.6
Industry
2.4
Forward
4.1
vs History
84
vs Industry
34
Median 3Y
7.5
Median 5Y
6.9
Industry
5
vs History
90
vs Industry
31
Median 3Y
14.1
Median 5Y
14
Industry
13.2
Forward
11.3
vs History
90
vs Industry
29
Median 3Y
18.5
Median 5Y
18.9
Industry
16.5
Forward
12.7
vs History
73
vs Industry
26
Median 3Y
18
Median 5Y
17.1
Industry
15
vs History
65
vs Industry
21
Median 3Y
21.8
Median 5Y
20.2
Industry
18.1
vs History
77
vs Industry
29
Median 3Y
2.9
Median 5Y
2.8
Industry
1.9

Multiples Across Competitors

JNJ Competitors Multiples
Johnson & Johnson Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Johnson & Johnson
NYSE:JNJ
361.8B USD 4.2 9.4 11.6 15
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
906.4B USD 25.2 147.5 71.9 81.6
DK
Novo Nordisk A/S
CSE:NOVO B
4.3T DKK 17.8 48.6 36.2 39.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Merck & Co Inc
NYSE:MRK
325.3B USD 5.3 140.6 35.2 57.3
UK
AstraZeneca PLC
NASDAQ:AZN
244.2B USD 5.1 38.6 19.3 30.7
CH
Roche Holding AG
SIX:ROG
206.2B CHF 3.5 18 10.1 11.9
CH
Novartis AG
SIX:NOVN
193.7B CHF 3.7 12.3 9.4 13.6
US
Pfizer Inc
NYSE:PFE
166.7B USD 3 -539.4 13 20.8
FR
Sanofi SA
PAR:SAN
115.5B EUR 1.6 12.7 5.9 7.6
P/E Multiple
Earnings Growth
US
Johnson & Johnson
NYSE:JNJ
Average P/E: 53.5
9.4
-21%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
147.5
340%
DK
Novo Nordisk A/S
CSE:NOVO B
48.6
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Merck & Co Inc
NYSE:MRK
140.6
7 578%
UK
A
AstraZeneca PLC
NASDAQ:AZN
38.6
172%
CH
Roche Holding AG
SIX:ROG
18
28%
CH
Novartis AG
SIX:NOVN
12.3
17%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -539.4
683%
FR
Sanofi SA
PAR:SAN
12.7
121%

See Also

Discover More